Thio treatment leads to the downregulation of FoxM1 at the RNA level, decreasing the proliferation rate in B-precursor acute lymphoblastic leukemia (B-pre-ALL)1. The gene discussed is FOXM1; the disease is acute lymphoblastic leukemia.